Arindom Pal
Johns Hopkins University
H-index: 9
North America-United States
Top articles of Arindom Pal
Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research …
The AAPS Journal
2024/4/8
Investigating inhibitors of 1-deoxy-d-xylulose 5-phosphate synthase in a mouse model of UTI
Microbiology Spectrum
2024/2/20
Arindom Pal
H-Index: 5
Rana Rais
H-Index: 20
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
Translational Neurodegeneration
2023/12/4
Neutral sphingomyelinase 2 inhibitors based on the pyrazolo [1, 5-a] pyrimidin-3-amine scaffold
European journal of medicinal chemistry
2019/5/15
ASENT 2023 Annual Meeting Abstracts
2023
nSMase2 inhibition reduces tau propagation in Alzheimer’s Disease mouse models
Alzheimer's & Dementia
2022/12
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
Science Advances
2022/11/16
Enhancing the Safety and Efficacy of PSMA-Based Small-Molecule Drug Conjugates by Linker Stabilization and Conjugation to Transthyretin Binding Ligand
Journal of Medicinal Chemistry
2022/11/3
Arindom Pal
H-Index: 5
Dendrimer-conjugated nSMase2 inhibitor reduces tau propagation in mice
Pharmaceutics
2022/9/28
D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II
Pharmaceutics
2022/9/23
Discovery of orally bioavailable and brain-penetrable prodrugs of the potent nSmase2 inhibitor DPTIP
Journal of medicinal chemistry
2022/8/5
Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury
Biochemical pharmacology
2021/12/1
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursor
Bioorganic & medicinal chemistry letters
2021/10/15
Glutamine antagonist GA-607 causes a dramatic accumulation of FGAR which can be used to monitor target engagement
Current drug metabolism
2021/8/8
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases
2021/7/1
BSCD Oral: Biological & Health Sciences
University of Chicago Undergraduate Research Symposium Proceedings
2020/5/28